EPCAM and cancer: As expected from a homogeneous cancer cell composition, no changes in the relative content of epithelial EpCAM+ and mesenchymal EpCAM− cancer cells vs. total cancer cells were observed after performing the ICB treatments on epithelial and mesenchymal mouse cSCCs (Figs. 4q–s and 5n, o).